ABBV-221
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-221, covering 2018-03-30 to 2018-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor [Phase 1]